A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

This work could advance the understanding of immune system responses and pave the way for improved vaccines and immunotherapies ...

The couple both live in Newhaven and owned a Peacehaven barber shop for 20 years. However, they have had to sell it to pay ...

The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...